기도 및 폐 스텐트 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the airway stent/lung stent market size was valued at USD 222.98 million in 2025 and estimated to grow from USD 239.52 million in 2026 to reach USD 342.77 million by 2031, at a CAGR of 7.42% during the forecast period (2026-2031).

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence Of Lung & Chronic Respiratory Disorders
  • 4.2.2 Growing Preference For Minimally Invasive Procedures
  • 4.2.3 Rapid Material Innovation: 3d-Printed & Drug-Eluting Bioresorbable Stents
  • 4.2.4 Benefits Associated with Usage of Pulmonary Stents
  • 4.2.5 Emergence Of Fully Biodegradable Stents and Innovative Stents
  • 4.2.6 Robotic Bronchoscopy Enabling Precise Stent Placement
• 4.3 Market Restraints
  • 4.3.1 Availability Of Alternative Interventions
  • 4.3.2 Device-Related Complications
  • 4.3.3 Reimbursement Gaps For Customized & Biodegradable Stents
  • 4.3.4 Regulatory Ambiguity For Patient-Specific 3D-Printed Devices
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technology Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size and Growth Forecasts (Value-USD)

• 5.1 By Product
  • 5.1.1 Self-Expandable Stents
  • 5.1.2 Balloon-Expandable Stents
  • 5.1.3 Non-Expandable / Customized 3D-Printed Stents
• 5.2 By Material
  • 5.2.1 Metal
  • 5.2.2 Silicone
  • 5.2.3 Hybrid (Covered / Composite)
  • 5.2.4 Bioresorbable Polymers
• 5.3 By Type
  • 5.3.1 Tracheobronchial Stents
  • 5.3.2 Laryngeal Stents
  • 5.3.3 Y-Shaped Carinal Stents
• 5.4 By Indication
  • 5.4.1 Malignant Central Airway Obstruction
  • 5.4.2 Benign Tracheal Stenosis
  • 5.4.3 Post-Lung-Transplant Airway Complications
  • 5.4.4 Tracheoesophageal Fistula
• 5.5 By End User
  • 5.5.1 Hospitals
  • 5.5.2 Ambulatory Surgical Centers
  • 5.5.3 Specialty Pulmonology Clinics
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.3.1 Boston Scientific Corporation
  • 6.3.2 Taewoong Medical Co. Ltd.
  • 6.3.3 Micro-Tech (Nanjing) Co. Ltd.
  • 6.3.4 Merit Medical Systems Inc.
  • 6.3.5 Cook Group Incorporated
  • 6.3.6 Endo-Flex GmbH
  • 6.3.7 Efer Endoscopy
  • 6.3.8 Bess Medizintechnik GmbH
  • 6.3.9 Standard Sci Tech Inc.
  • 6.3.10 E. Benson Hood Laboratories Inc.
  • 6.3.11 Novatech SA
  • 6.3.12 M.I. Tech Co. Ltd.
  • 6.3.13 A.B. Polyp Co. Ltd.
  • 6.3.14 Stening SRL
  • 6.3.15 Hyundai Medical Co. Ltd.
  • 6.3.16 Bentley Innomed GmbH
  • 6.3.17 Olympus Corporation
  • 6.3.18 Medtronic plc

7 Market Opportunities and Future Outlook

• 7.1 White-Space and Unmet-Need Assessment